Mitesco, Inc. (MITI)
OTCMKTS · Delayed Price · Currency is USD
0.1500
+0.0100 (7.14%)
Aug 22, 2025, 4:00 PM EDT
Mitesco Market Cap
Mitesco has a market cap or net worth of $1.76 million as of August 25, 2025. Its market cap has decreased by -1.07% in one year.
Market Cap
1.76M
Enterprise Value
16.16M
Revenue
73.40K
Ranking
n/a
PE Ratio
0.84
Stock Price
$0.15
Market Cap Chart
Since December 11, 2015, Mitesco's market cap has increased from 636.26K to 1.76M, an increase of 176.84%. That is a compound annual growth rate of 11.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 1.76M | -60.37% |
| Dec 31, 2024 | 4.44M | 2,560.84% |
| Dec 29, 2023 | 167.04K | -96.60% |
| Dec 30, 2022 | 4.91M | -85.96% |
| Dec 31, 2021 | 34.96M | 770.80% |
| Dec 31, 2020 | 4.01M | 10.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |